{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:30:30Z","timestamp":1782883830526,"version":"3.54.5"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Histological transformation (HT) is an exceptionally uncommon and poorly understood event where a low-grade or indolent B-cell lymphoma transforms into a more aggressive entity, typically diffuse large B-cell lymphoma (DLBCL). The pathogenesis is unclear; however, HT is associated with a worse prognosis. This article reports a unique case of marginal zone lymphoma (MZL) limited to skin\/subcutis (confirmed with PET-CT) that subsequently developed DLBCL, followed by nodal MZL. We explored phenotypic, molecular genetic, and cytogenetic findings in subcutaneous MZL with HT to DLBCL and subsequent progression to systemic MZL. Shared clonal peaks between the tumors were demonstrated through immunoglobulin heavy chain PCR, and genomic microarray analysis revealed both unique genomic abnormalities and shared regions of copy-neutral loss of heterozygosity in all specimens. BCL-2 expression was present in the original subcutaneous MZL, lost on conversion to Primary cutaneous diffuse large B cell lymphoma (PCDLBCL)-NOS, and regained during subsequent transformation to systemic MZL. The PCDLBCL-NOS did not demonstrate FISH rearrangements for MYC, BCL2, and BCL6. Here, we describe the histologic, immunophenotypic, and cytogenetic abnormalities of the clonally related transformation of subcutaneous MZL, PCDLBCL-NOS, and eventual systemic MZL. The predominantly subcutaneous presentation of MZL may be associated with a more aggressive outcome and raises consideration for careful evaluation of patients who present with this pattern.<\/jats:p>","DOI":"10.1097\/dad.0000000000002053","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T14:00:09Z","timestamp":1652882409000},"page":"442-448","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Histological Transformation and Clonal Relationship of Subcutaneous Marginal Zone B-Cell Lymphoma and Diffuse Large B-Cell Lymphoma"],"prefix":"10.1097","volume":"44","author":[{"given":"James","family":"Abbott","sequence":"first","affiliation":[{"name":"Dermatology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Corean","sequence":"additional","affiliation":[{"name":"Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laggis","sequence":"additional","affiliation":[{"name":"Dermatology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Halwani","sequence":"additional","affiliation":[{"name":"Hematology and Oncology, University of Utah Health Sciences Center, Salt Lake City, Utah;"},{"name":"Division of Hematopathology, Huntsman Cancer Institute, Salt Lake City, UT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reha","family":"Toydemir","sequence":"additional","affiliation":[{"name":"Pathology, and"},{"name":"Division of Pediatric Genetics, ARUP Laboratories and Institute for Clinical & Experimental Pathology."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Miles","sequence":"additional","affiliation":[{"name":"Pathology, and"},{"name":"Division of Hematopathology, Huntsman Cancer Institute, Salt Lake City, UT; and"},{"name":"Division of Pediatric Genetics, ARUP Laboratories and Institute for Clinical & Experimental Pathology."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Florell","sequence":"additional","affiliation":[{"name":"Dermatology;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wada","sequence":"additional","affiliation":[{"name":"Dermatology;"},{"name":"Division of Hematopathology, Huntsman Cancer Institute, Salt Lake City, UT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: Part I. Clinical features, diagnosis, and classification","volume":"69","author":"Su\u00e1rez","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"R2-20250616","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood."},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2000.03471.x","article-title":"Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases","volume":"142","author":"Gr\u00f8nb\u00e6k","year":"2000","journal-title":"Br J Dermatol."},{"key":"R4-20250616","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","article-title":"Histologic transformation in marginal zone lymphomas","volume":"26","author":"Conconi","year":"2015","journal-title":"Ann Oncol."},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0b013e318267495f","article-title":"Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaad.2008.04.012","article-title":"Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome in primary cutaneous marginal zone lymphoma","volume":"59","author":"Gerami","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00000478-200308000-00003","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 Asian cases","volume":"27","author":"Li","year":"2003","journal-title":"Am J Surg Pathol."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3324\/haematol.2011.057422","article-title":"Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphoma","volume":"97","author":"Jonak","year":"2012","journal-title":"Haematologica."},{"key":"R11-20250616","first-page":"275","article-title":"Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: clinical, morphologic and prognostic differences","volume":"17","author":"Felcht","year":"2019","journal-title":"J Ger Soc Dermatol."},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J Invest Dermatol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J Invest Dermatol."},{"key":"R15-20250616","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jid.2018.04.038","article-title":"Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B-cell lymphoma, leg type","volume":"138","author":"Zhou","year":"2018","journal-title":"J Invest Dermatol."},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bjh.14153","article-title":"Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients","volume":"174","author":"Maeshima","year":"2016","journal-title":"Br J Haematol."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/gcc.20613","article-title":"The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1","volume":"47","author":"Parker","year":"2008","journal-title":"Genes Chromosomes Cancer."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1158\/1078-0432.CCR-12-0845","article-title":"Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas","volume":"18","author":"Gonzalez-Aguilar","year":"2012","journal-title":"Clin Cancer Res."},{"key":"R19-20250616","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet."},{"key":"R20-20250616","first-page":"13","article-title":"TBL1XR1 in physiological and pathological states","volume":"3","author":"Li","year":"2015","journal-title":"Am J Clin Exp Urol."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"20502","DOI":"10.1074\/jbc.M114.569889","article-title":"Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model","volume":"289","author":"Jones","year":"2014","journal-title":"J Biol Chem."},{"key":"R22-20250616","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cell.2020.05.049","article-title":"TBL1XR1 mutations drive extranodal lymphoma by inducing a pro-tumorigenic memory fate","volume":"182","author":"Venturutti","year":"2020","journal-title":"Cell."},{"key":"R23-20250616","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood."},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrc2986","article-title":"For better or for worse: the role of Pim oncogenes in tumorigenesis","volume":"11","author":"Nawijn","year":"2011","journal-title":"Nat Rev Cancer."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"40","DOI":"10.6026\/97320630015040","article-title":"A review on PIM kinases in tumors","volume":"15","author":"Arrouchi","year":"2019","journal-title":"Bioinformation."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.leu.2404094","article-title":"Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin\u2019s lymphomas [13]","volume":"20","author":"Sivertsen","year":"2006","journal-title":"Leukemia."},{"key":"R27-20250616","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:02:20Z","timestamp":1750100540000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002053","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}